Dr. Katrin Rupalla

Dr. Katrin Rupalla has more than 25 years of experience in research & drug development, primarily in the areas of oncology, immunology and neurology. She is currently SVP, Global Head of Regulatory Affairs, Medical Documentation & R&D Quality at Lundbeck, Copenhagen, Denmark. Prior to joining Lundbeck, Dr. Rupalla worked in several leadership positions at Bristol-Myers Squibb, including as VP, Global Head of Regulatory Oncology based in Princeton, NJ, US and VP, Head of Development China based in Shanghai. Her Regulatory and Drug Development career includes several world-wide approvals of major products, such as REVLIMID®, OPDIVO® and YERVOY®, in the US, Europe and China as well as a multitude of new indication approvals. Dr. Rupalla is a certified pharmacist and obtained her PhD from Philipps University of Marburg, Germany in Pharmacology and Neurobiology and did postgraduate work in CNS Pharmacology at the University of Aachen/Novartis before starting her career in Drug Development at Roche.